Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 57, Issue 9, Pages 3612-3622Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm401006s
Keywords
-
Categories
Funding
- U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [1R01A1059372]
- COST Action [BM 1003, CM1102]
- Italian Ministry of University and Research (MIUR), PRIN Project Italian Network for the Development of Multivalent Nanosystems
Ask authors/readers for more resources
Toll-like receptor 4 (TLR4), together with MD-2, binds bacterial endotoxins (E) with high affinity, triggering formation of the activated homodimer (E.MD-2.TLR4)(2). Activated TLR4 induces intracellular signaling leading to activation of transcription factors that result in cytokine and chemokine production and initiation of inflammatory and immune responses. TLR4 also responds to endogenous ligands called danger associated molecular patterns (DAMPs). Increased sensitivity to infection and a variety of immune pathologies have been associated with either too little or too much TLR4 activation. We review here the molecular mechanisms of TLR4 activation (agonism) or inhibition (antagonism) by small organic molecules of both natural and synthetic origin. The role of co-receptors MD-2 and CD14 in the TLR4 modulation process is also discussed. Recent achievements in the field of chemical TLR4 modulation are reviewed, with special focus on nonclassical TLR4 ligands with a chemical structure different from that of lipid A.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available